MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,051,868 | -22.1% | 1,704,902 | -3.2% | 0.00% | -33.3% |
| Q2 2023 | $21,900,242 | -7.9% | 1,761,885 | +3.8% | 0.00% | 0.0% |
| Q1 2023 | $23,789,457 | +98824.9% | 1,698,033 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $24,048 | -99.9% | 1,680,522 | +0.7% | 0.00% | -50.0% |
| Q3 2022 | $42,586,000 | -8.0% | 1,668,086 | +2.4% | 0.01% | -14.3% |
| Q2 2022 | $46,296,000 | -11.3% | 1,629,600 | +10.1% | 0.01% | 0.0% |
| Q1 2022 | $52,220,000 | -12.6% | 1,480,580 | +3.8% | 0.01% | 0.0% |
| Q4 2021 | $59,761,000 | -8.8% | 1,426,294 | +6.8% | 0.01% | -22.2% |
| Q3 2021 | $65,540,000 | +40.1% | 1,335,377 | +19.1% | 0.01% | +50.0% |
| Q2 2021 | $46,785,000 | +64.7% | 1,121,156 | +40.6% | 0.01% | +50.0% |
| Q1 2021 | $28,412,000 | +1472.3% | 797,208 | +1137.2% | 0.00% | – |
| Q4 2020 | $1,807,000 | – | 64,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |